Photocure stock in correction after Q4 2018 report - time to buy

By savepiginvest
Updated
As mentioned in an earlier Idea ( https://www.tradingview.com/chart/PHO/JhvyiyX8-Photocure-PHO-OL-stock-rally-ahead-of-Q4-report-One-to-watch/ ), the Q4 report represented a substantial risk for a downwards reaction after a recent surge in the share price.

At the new price level around NOK 41 the stock is much more attractively priced, and this could be the time to move in for new investors.
Trade active
PHO.OL ticking upwards after consolidating at the NOK 39-40 level for some days.
Trade active
The post Q4 swing trade idea still in play, keep on to your shares.
Trade active
Swing trade for Photocure still in effect, and yesterdays news could be the catalyst that starts a push towards sell zone.
Trade closed: target reached
Target for this trade reached today, though further upside potential is still present.
Beyond Technical AnalysisbiotechbladdercancerTechnical IndicatorsmedtechTrend Analysis
savepiginvest

Related publications

Disclaimer